Most sold healthcare stocks in Q4 2014

See which Healthcare stocks institutional investors trimmed or exited the most in Q4 2014, measured as net reductions in reported share positions from Q3 2014 into Q4 2014. Notable reductions at the top of this list include BOSTON SCIENTIFIC CORP (BSX), STRYKER CORP (SYK), ABBVIE INC (ABBV), JOHNSON & JOHNSON (JNJ). These rankings are based on SEC 13F filings from the investors we track.

SymbolNameNet sharesNet valueNewAddedTrimmedSold outHolding now
BSXBOSTON SCIENTIFIC CORP-40,150,208-$464.79K01102
SYKSTRYKER CORP-11,964,919-$829.05K01415
ABBVABBVIE INC-11,605,939-$627.64K21427
JNJJOHNSON & JOHNSON-8,772,489-$979.64K0610018
PDCOPATTERSON COS INC-6,346,959-$199.43K01415
BDXBECTON DICKINSON AND CO-4,526,896-$297.27K045110
ABTABBOTT LABORATORIES-3,558,289-$60.12K019010
MRKMERCK & CO. INC.-2,742,607-$248.50K026111
TMOTHERMO FISHER SCIENTIFIC INC-2,202,809-$219.72K045010
GILDGILEAD SCIENCES INC-1,661,065-$290.73K283013
PHGKONINKLIJKE PHILIPS NVR- NY-1,544,308-$134.86K00303
ACADACADIA PHARMACEUTICALS INC-1,368,624-$13.22K00101
MOHMOLINA HEALTHCARE INC-1,124,232-$45.50K01011
REGNREGENERON PHARMACEUTICALS-1,116,853-$375.68K00121
LLYELI LILLY & CO-1,059,185-$50.60K01314
TFXTELEFLEX INC-792,164-$68.35K01304
CVSCVS HEALTH CORP-654,474$40.01K00707
GERNGERON CORP-639,378$67010102
SRDXSURMODICS INC-615,550-$8.02K01203
GMEDGLOBUS MEDICAL INC - A-602,400-$10.82K00101
RMDRESMED INC-547,100-$23.88K10011
PBHPRESTIGE CONSUMER HEALTHCARE-527,964-$17.09K00010
CYTKCYTOKINETICS INC-498,161-$1.75K00010
NVONOVO-NORDISK A/S-SPONS ADR-490,608-$106.15K01102
CPIXCUMBERLAND PHARMACEUTICALS-485,025-$10101102
SEMSELECT MEDICAL HOLDINGS CORP-390,300-$4.70K00010
MCKMCKESSON CORP-338,784-$57.75K00111
ZBHZIMMER BIOMET HOLDINGS INC-321,440-$5.17K00608
ARAYACCURAY INC-319,040-$2.03K00101
WSTWEST PHARMACEUTICAL SERVICES-312,200-$6.00K00101
GRFSGRIFOLS SA-ADR-271,900-$9.66K00101
BRKRBRUKER CORP-255,960-$4.74K00010
MASIMASIMO CORP-236,100-$4.52K00101
CPRXCATALYST PHARMACEUTICALS INC-196,500-$65200010
RDNTRADNET INC-195,600-$64700101
CNMDCONMED CORP-180,481-$6.65K00010
RGENREPLIGEN CORP-161,200-$3.29K00101
AAGILENT TECHNOLOGIES INC-159,478-$81.21K02123
ILMNILLUMINA INC-114,265$162.31K01103
CCRNCROSS COUNTRY HEALTHCARE INC-89,100-$62800101
ENTAENANTA PHARMACEUTICALS INC-83,277-$3.29K00010
NEOGNEOGEN CORP-81,013-$3.20K00010
AMNAMN HEALTHCARE SERVICES INC-75,200-$94300101
ATRAPTARGROUP INC-75,100-$4.30K00102
NEONEOGENOMICS INC-65,800-$48500101
FMSFRESENIUS MEDICAL CARE-ADR-61,800-$2.09K00101
AORTARTIVION INC-61,700-$14500101
PFMTPERFORMANT FINANCIAL CORP-60,700-$77600101
OSURORASURE TECHNOLOGIES INC-59,700$96100101
ANIKANIKA THERAPEUTICS INC-57,800-$1.25K00101
20 symbols with net change in reported shares from tracked managers.−44.2M−33.1M−22.1M−11.0M0.00Net change in reported shares (tracked managers)BSXSYKABBVJNJPDCOBDXABTMRKTMOGILDPHGACADMOHREGNLLYTFXCVSGERNSRDXGMEDSymbol

Frequently asked questions about Most sold healthcare stocks in Q4 2014

  • What are the most sold Healthcare stocks in Q4 2014?

    The most sold healthcare stocks in Q4 2014 are those with the largest decrease in reported share counts across tracked institutional investors compared to Q3 2014, based on SEC 13F filings.

  • Which healthcare stocks did institutional investors trimmed or exited the most in Q4 2014?

    Among the managers we track, net reductions were largest in companies such as BOSTON SCIENTIFIC CORP (BSX), STRYKER CORP (SYK), ABBVIE INC (ABBV), based on aggregated 13F data.

  • How is institutional selling calculated?

    Selling is calculated by summing the net decrease in shares reported by tracked investors between two consecutive quarterly 13F snapshots (compared to Q3 2014).

  • Does this include all institutional owners?

    These rankings are based on a subset of tracked institutional investors who file SEC 13F reports. While not exhaustive, the dataset includes many of the largest and most influential funds.

  • Are these trades real-time?

    No. 13F filings are reported quarterly and may be delayed by up to 45 days. The data reflects positions at the end of the reporting period, not real-time trading activity.